Discontinued — last reported Q4 '25

Business Sale Proceeds

Investing

UnitedHealth Group Business Sale Proceeds remained flat by 0.0% to $510.25M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 198.0%, from $171.25M to $510.25M. Over 3 years (FY 2021 to FY 2024), Business Sale Proceeds shows an upward trend with a 414.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2019
Last reportedQ4 2025

How to read this metric

Inflows represent capital recycling or strategic pruning of the portfolio.

Detailed definition

Cash inflows resulting from the divestiture of business units, subsidiaries, or assets. This metric highlights the compa...

Peer comparison

Standard investing activity metric for companies undergoing restructuring or portfolio optimization.

Metric ID: cf_proceeds_from_sale_of_business

Historical Data

4 years
 FY'21FY'22FY'23FY'24
Value$15.00M$3.41B$685.00M$2.04B
YoY Change>999%-79.9%+198.0%
Range$15.00M$3.41B
CAGR+414.3%
Avg YoY Growth>999%
Median YoY Growth+198.0%

Business Sale Proceeds at Other Companies

Frequently Asked Questions

What is UnitedHealth Group's business sale proceeds?
UnitedHealth Group (UNH) reported business sale proceeds of $510.25M in Q4 2024.
How has UnitedHealth Group's business sale proceeds changed year-over-year?
UnitedHealth Group's business sale proceeds increased by 198.0% year-over-year, from $171.25M to $510.25M.
What is the long-term trend for UnitedHealth Group's business sale proceeds?
Over 3 years (2021 to 2024), UnitedHealth Group's business sale proceeds has grown at a 414.3% compound annual growth rate (CAGR), from $15.00M to $2.04B.
What does business sale proceeds mean?
Cash received from selling off business units or assets.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.